Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model

Breast Cancer Research and Treatment

Volumn 118, Issue 3, 2009, Pages 469-480

  Grossoni, Valeria C ^a   Todaro, Laura B ^a   Kazanietz, Marcelo G ^b   De Kier Joffé, Elisa D Bal ^a   Urtreger, Alejandro J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Metastasis dissemination; PKC 1; PKC ; Proliferation; Survival; Tumor growth

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MOUSE; EXTRACELLULAR MATRIX; FEMALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; TRANSFECTION;

EID: 70449553663     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0299-4     Document Type: Article

References (56)

1. LV Dekker PJ Parker 1994 Protein kinase C-a question of specificity Trends Biochem Sci 19 73 77 10.1016/0968-0004(94)90038-8 10.1016/0968-0004(94) 90038-8 8160269 (Pubitemid 24055564)
2. SC Kiley KJ Clark SK Duddy, et al. 1999 Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression Oncogene 18 6748 6757 10.1038/sj.onc.1203101 10.1038/sj.onc.1203101 10597283
3. Y Nishizuka 1995 Protein kinase C and lipid signaling for sustained cellular responses FASEB J 9 484 496 7737456
4. H Mellor PJ Parker 1998 The extended protein kinase C superfamily Biochem J 332 Pt 2 281 292 9601053
5. AC Newton 1997 Regulation of protein kinase C Curr Opin Cell Biol 9 161 167 10.1016/S0955-0674(97)80058-0 10.1016/S0955-0674(97)80058-0 9069266 (Pubitemid 27135982)
6. AC Newton 1995 Protein kinase C: structure, function, and regulation J Biol Chem 270 28495 28498 10.1074/jbc.270.43.25526 10.1074/jbc.270.43.25526 7499357
7. PC Gordge MJ Hulme RA Clegg, et al. 1996 Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue Eur J Cancer 32A 2120 2126 10.1016/S0959-8049(96)00255-9 10.1016/S0959-8049(96)00255-9 9014755 (Pubitemid 26419463)
8. MA McCracken LJ Miraglia RA McKay, et al. 2003 Protein kinase C delta is a prosurvival factor in human breast tumor cell lines Mol Cancer Ther 2 273 281 12657722
9. Y Gokmen-Polar NR Murray MA Velasco, et al. 2001 Elevated protein kinase C beta II is an early promotive event in colon carcinogenesis Cancer Res 61 1375 1381 11245437
10. RP Regala C Weems L Jamieson, et al. 2005 Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer Cancer Res 65 8905 8911 10.1158/0008-5472.CAN-05-2372 10.1158/0008-5472.CAN-05-2372 16204062 (Pubitemid 41377380)
11. SA Lee JW Karaszkiewicz WB Anderson 1992 Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells Cancer Res 52 3750 3759 1617646
12. DK Ways CA Kukoly J deVente, et al. 1995 MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype J Clin Invest 95 1906 1915 10.1172/JCI117872 10.1172/JCI117872 7706498
13. DA Tonetti MJ Chisamore W Grdina, et al. 2000 Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines Br J Cancer 83 782 791 10.1054/bjoc.2000.1326 10.1054/bjoc.2000.1326 10952784
14. R Koren D Ben Meir L Langzam, et al. 2004 Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate Oncol Rep 11 321 326 14719062
15. Q Pan LW Bao CG Kleer, et al. 2005 Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy Cancer Res 65 8366 8371 10.1158/0008-5472.CAN- 05-0553 10.1158/0008-5472.CAN-05-0553 16166314 (Pubitemid 41330602)
16. XH Jiang SK Lam MC Lin, et al. 2002 Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway Oncogene 21 6113 6122 10.1038/sj.onc.1205778 10.1038/sj.onc.1205778 12203123
17. BA Teicher K Menon E Alvarez, et al. 2001 Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts In Vivo 15 185 193 11491013 (Pubitemid 32705446)
18. DR Goldstein AM Cacace IB Weinstein 1995 Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression Carcinogenesis 16 1121 1126 10.1093/carcin/16.5.1121 10.1093/carcin/16.5.1121 7767974
19. DE Macfarlane L Manzel 1994 Activation of beta-isozyme of protein kinase C (PKC beta) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PKC beta-defective PET mutant J Biol Chem 269 4327 4331 8308000
20. MB Powell RK Rosenberg MJ Graham, et al. 1993 Protein kinase C beta expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate J Cancer Res Clin Oncol 119 199 206 10.1007/BF01624431 10.1007/BF01624431 7678596 (Pubitemid 23026559)
21. D Wu TL Foreman CW Gregory, et al. 2002 Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer Cancer Res 62 2423 2429 11956106
22. MA McJilton C Van Sikes GG Wescott, et al. 2003 Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells Oncogene 22 7958 7968 10.1038/sj.onc.1206795 10.1038/sj.onc.1206795 12970744 (Pubitemid 37175861)
23. MH Aziz HT Manoharan AK Verma 2007 Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3 Cancer Res 67 1385 1394 10.1158/0008-5472.CAN-06-3350 10.1158/0008-5472.CAN-06-3350 17283176 (Pubitemid 46270800)
24. W Lin SM Wang TF Huang, et al. 2002 Differential regulation of fibronectin fibrillogenesis by protein kinases A and C Connect Tissue Res 43 22 31 10.1080/713713428 10.1080/713713428 12180265
25. A Urtreger F Porro L Puricelli, et al. 1998 Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis Int J Cancer 78 233 241 10.1002/(SICI)1097- 0215(19981005)78:2<233::AID-IJC18>3.0.CO;2-B 10.1002/(SICI)1097- 0215(19981005)78:2<233::AID-IJC18>3.0.CO;2-B 9754657 (Pubitemid 28443182)
26. KA Green LR Lund 2005 ECM degrading proteases and tissue remodelling in the mammary gland Bioessays 27 894 903 10.1002/bies.20281 10.1002/bies.20281 16108064 (Pubitemid 41415944)
27. L Ossowski D Biegel E Reich 1979 Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue Cell 16 929 940 10.1016/0092-8674(79)90108-9 10.1016/0092-8674(79)90108-9 455456
28. N Thomasset A Lochter CJ Sympson, et al. 1998 Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development Am J Pathol 153 457 467 9708806
29. E Skrzydlewska M Sulkowska M Koda, et al. 2005 Proteolytic- antiproteolytic balance and its regulation in carcinogenesis World J Gastroenterol 11 1251 1266 15761961
30. J Juarez G Clayman M Nakajima, et al. 1993 Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity Int J Cancer 55 10 18 10.1002/ijc.2910550104 10.1002/ijc.2910550104 7688350
31. JA Aguirre-Ghiso DF Alonso EF Farias, et al. 1997 Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells BBA 1356 171 184 9150275
32. JA Aguirre Ghiso DF Alonso EF Farias, et al. 1999 Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype Eur J Biochem 263 295 304 10.1046/j.1432-1327.1999.00507.x 10.1046/j.1432-1327.1999.00507.x 10406935 (Pubitemid 29337018)
33. PA Masso-Welch G Verstovsek MM Ip 1999 Alterations in the expression and localization of protein kinase C isoforms during mammary gland differentiation Eur J Cell Biol 78 497 510 10472802
34. M Egeblad Z Werb 2002 New functions for matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 10.1038/nrc745 10.1038/nrc745 11990853
35. AJ Urtreger V Ladeda MC Vidal, et al. 1997 Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines Int J Oncol 11 489 496
36. AJ Urtreger VC Grossoni KB Falbo, et al. 2005 Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells Mol Carcinog 42 29 39 10.1002/mc.20066 10.1002/mc.20066 15546134 (Pubitemid 40041483)
37. AJ Urtreger JA Aguirre Ghiso SE Werbajh, et al. 1999 Involvement of fibronectin in the regulation of urokinase production and binding in murine mammary tumor cells Int J Cancer 82 748 753 10.1002/(SICI)1097-0215(19990827)82: 5<748::AID-IJC20>3.0.CO;2-R 10.1002/(SICI)1097-0215(19990827)82:5<748:: AID-IJC20>3.0.CO;2-R 10417775
38. DF Alonso EF Farias A Urtreger, et al. 1996 Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma J Surg Oncol 62 288 297 10.1002/(SICI)1096- 9098(199608)62:4<288::AID-JSO14>3.0.CO;2-1 10.1002/(SICI)1096-9098(199608) 62:4<288::AID-JSO14>3.0.CO;2-1 8691844 (Pubitemid 26262354)
39. JA Aguirre Ghiso K Kovalski L Ossowski 1999 Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J Cell Biol 147 89 104 10.1083/jcb.147.1.89 10.1083/jcb.147.1.89 10508858 (Pubitemid 30211799)
40. M Zhong Z Lu DA Foster 2002 Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression Oncogene 21 1071 1078 10.1038/sj.onc.1205165 10.1038/sj.onc.1205165 11850824
41. G Gliki C Wheeler-Jones I Zachary 2002 Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3'-kinase-mediates PKC delta phosphorylation: role of PKC in angiogenesis Cell Biol Int 26 751 759 10.1016/S1065-6995(02)90926-1 10.1016/S1065-6995(02)90926-1 12377207 (Pubitemid 35266492)
42. Y Tanaka MV Gavrielides Y Mitsuuchi, et al. 2003 Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway J Biol Chem 278 33753 33762 10.1074/jbc.M303313200 10.1074/jbc.M303313200 12824193 (Pubitemid 37553209)
43. L Li K Sampat N Hu, et al. 2006 Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes J Biol Chem 281 3237 3243 10.1074/jbc.M512167200 10.1074/jbc.M512167200 16338928 (Pubitemid 43845935)
44. V Bumaschny A Urtreger M Diament, et al. 2004 Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model Breast Cancer Res 6 R116 R129 10.1186/bcr757 10.1186/bcr757 14979922
45. Y Mao JE Schwarzbauer 2005 Fibronectin fibrillogenesis, a cell-mediated matrix assembly process Matrix Biol 24 389 399 10.1016/j.matbio.2005.06.008 10.1016/j.matbio.2005.06.008 16061370 (Pubitemid 41765018)
46. E Ruoslahti 1984 Fibronectin in cell adhesion and invasion Cancer Metastas Rev 3 43 51 10.1007/BF00047692 10.1007/BF00047692
47. Z Siskova W Baron H de Vries, et al. 2006 Fibronectin impedes "myelin" sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking Mol Cell Neurosci 33 150 159 10.1016/j.mcn.2006.07.001 10.1016/j.mcn.2006.07.001 16935002 (Pubitemid 44415490)
48. H Ha MR Yu HB Lee 2001 High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells Kidney Int 59 463 470 10.1046/j.1523-1755.2001.059002463.x 10.1046/j.1523-1755.2001. 059002463.x 11168928 (Pubitemid 32157911)
49. SE Werbajh AJ Urtreger LI Puricelli, et al. 1998 Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells FEBS Lett 440 277 281 10.1016/S0014-5793(98)01473-2 10.1016/S0014-5793(98)01473-2 9872386 (Pubitemid 29052298)
50. S Montaner A Ramos R Perona, et al. 1995 Overexpression of PKC zeta in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF kappa B activity Oncogene 10 2213 2220 7784066
51. PA Andreasen L Kjoller L Christensen, et al. 1997 The urokinase-type plasminogen activator system in cancer metastasis: a review Int J Cancer 72 1 22 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z 9212216 (Pubitemid 27314632)
52. SM Ranuncolo E Armanasco C Cresta, et al. 2003 Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients Int J Cancer 20 745 751 10.1002/ijc.11288 10.1002/ijc.11288 (Pubitemid 36993399)
53. E Mazzoni A Adam ED Bal de Kier Joffe, et al. 2003 Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo Mol Cancer Res 1 776 787 12939403
54. D Sliva 2004 Signaling pathways responsible for cancer cell invasion as targets for cancer therapy Curr Cancer Drug Targets 4 327 336 10.2174/1568009043332961 10.2174/1568009043332961 15180498 (Pubitemid 38797244)
55. D Ron MG Kazanietz 1999 New insights into the regulation of protein kinase C and novel phorbol ester receptors FASEB J 13 1658 1676 10506570
56. EM Griner MG Kazanietz 2007 Protein kinase C and other diacylglycerol effectors in cancer Nat Rev Cancer 7 281 294 10.1038/nrc2110 10.1038/nrc2110 17384583 (Pubitemid 46480971)